You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RYTM Exercise Disclosure
Garfield Alastair · SEC Form 4 · Filed Jul 2, 2026
Exercise
Reported value range
Not reported
Garfield Alastair Chief Scientific Officer
RYTM
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
RYTM daily price context
Close on/before transaction
$110.41
Jul 1, 2026
First close after public filing
$111.68
Jul 6, 2026
30-day return after filing
-7.97%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,445 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-080397
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$237.38K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rhythm Pharmaceuticals, Inc. RYTM Current | Exercise | Jul 1, 2026 | Not reported |
| Rhythm Pharmaceuticals, Inc. RYTM | Disposition | Jul 1, 2026 | $237.38K |
| Rhythm Pharmaceuticals, Inc. RYTM | Exercise | Jul 1, 2026 | $0 |